|Bioquell plc -- USA Stock|| |
USD 3.50 0.00 0.00%
Mr. Christopher Harwood Bernard Mills is an Independent NonExecutive Director of Bioquell PLC., since December 18, 2012. He Joined the Board in December 2012. He is Chief Executive and Investment Manager of North Atlantic Smaller Companies Investment Trust PLC, a director of Oryx International Growth Fund Ltd and is the Chief Investment Officer and a member of Harwood Capital LLP.
Age: 63 Director Since 2012
44 1264 835 900 http://www.bioquellplc.com
Mills is also a director of Sunlink Health Systems Inc, Bionostics Holdings Limited, Hampton Investment Properties, Second London American Trust PLC, Glass America, Inc, Progeny, Inc, Global Options, Celsis International Limited and MJ Gleeson PLC.
Christopher Mills Latest Insider Activity
The company has return on total asset (ROA)
of 5.32 %
which means that it generated profit of $5.32 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE)
of 5.16 %
meaning that it generated $5.16 on every $100 dollars invested by stockholders.
Bioquell PLC designs, manufactures, and supplies bio-decontamination and containment equipment, and related products and services to the pharmaceutical, healthcare, food, and defense industries in the United Kingdom and internationally. The company was incorporated in 1925 and is headquartered in Andover, the United Kingdom. Bioquell plc is traded on OTC Market in USA.Bioquell plc (BIQLF) is traded on OTC Market in USA. It is located in 52 Royce Close and employs 200 people.